In a big relief for parents, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.
Hyderabad-based Bharat Biotech has been granted permission to conduct the phase 2 and phase 3 clinical trials of its COVID-19 vaccine ‘Covaxin’ on children between the 2 to age 18.
After Covishield Covid Vaccine, which arrived in Odisha yesterday, Covaxin vaccine manufactured by Bharat Biotech, also reached Odisha. 20,000 doses of Covaxin Covid 19 vaccine arrived at the Bhubaneswar Airport, Odisha this morning.
Applications for the emergency use of Covid-19 vaccine by Serum Institute of India (SII) and Bharat Biotech are not rejected.
Haryana Health Minister Anil Vij, who was administered a trial dose of a coronavirus vaccine ‘Covaxin’, has tested positive for the Covid-19 infection.
TNI Bureau: In a big development, which may script a new chapter in global medical history, India has set a deadline of August 15 to complete all clinical trials and launch the first-ever COVID-19 vaccine in the country, as per the reports…